AKBA
Akebia Therapeut (AKBA)
NASDAQ
$0.92+$0.02 (+1.92%)
Price as of Aug 21, 2026 7:55 PM EDT
  • $251.2M
    Market Cap
  • -71.58%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 62
Valuation
AKBA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 31
Valuation
AKBA
vs History
vs S&P 500
3-Month Momentum
36.30%
12-Month Momentum
-61.76%
3-Month Risk Adjusted Momentum
138.94%
12-Month Risk Adjusted Momentum
-87.33%

True Yield

N/A
Valuation
AKBA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-0.13%

Financial Health Score

Score: 85
Valuation
AKBA
vs History
vs S&P 500
Ohlson's O-Score
7